Antihypertensive medications and risk for incident dementia and Alzheimer's disease: a meta-analysis of individual participant data from prospective cohort studies

MLA

Vilmundur Guðnason, et al. “Antihypertensive Medications and Risk for Incident Dementia and Alzheimer’s Disease: A Meta-Analysis of Individual Participant Data from Prospective Cohort Studies.” Lancet Neurology, vol. 19, no. 1, Jan. 2020, pp. 61–70. EBSCOhost, https://doi.org/10.1016/s1474-4422(19)30393-x.

APA

Vilmundur Guðnason, Phillip J. Tully, Caroline L. Phillips, Rebecca F. Gottesman, Osorio Meirelles, Alexa S. Beiser, B. Gwen Windham, Jayandra J. Himali, Sudha Seshadri, Stéphanie Debette, Thomas H. Mosley, Lenore J. Launer, Kendra Davis-Plourde, Lon R. White, Michael Griswold, Sanaz Sedaghat, M. Arfan Ikram, Jie Ding, Wanmei Wang, … Matthew P. Pase. (2020). Antihypertensive medications and risk for incident dementia and Alzheimer’s disease: a meta-analysis of individual participant data from prospective cohort studies. Lancet Neurology, 19(1), 61–70. https://doi.org/10.1016/s1474-4422(19)30393-x

Chicago

Vilmundur Guðnason, Phillip J. Tully, Caroline L. Phillips, Rebecca F. Gottesman, Osorio Meirelles, Alexa S. Beiser, B. Gwen Windham, et al. 2020. “Antihypertensive Medications and Risk for Incident Dementia and Alzheimer’s Disease: A Meta-Analysis of Individual Participant Data from Prospective Cohort Studies.” Lancet Neurology 19 (1): 61–70. doi:10.1016/s1474-4422(19)30393-x.